Метилирование ДНК при цервикальной интраэпителиальной неоплазии и раке шейки матки

1. Ашрафян Л.А., Киселев В.И., Кузнецов И.Н., Серова О.Ф., Узденова З.Х., Герфанова Е.В. Рак шейки матки: проблемы профилактики и скрининга в Российской Федерации. Доктор.Ру. 2019; 11(166): 50-4.
2. Ершов В.А. Концепции генеза ВПЧ-ассоциированной цервикальной неоплазии. Новости клинической цитологии России. 2021; 25(1): 20-9.
3. Файзулоев Е.Б., Каира А.Н., Узбеков А.А., Поромов А.А., Волынская Е.А., Свитич О.А., Зверев В.В. Распространенность папилломавирусов человека высокого и низкого онкогенного риска на территории Российской Федерации. Молекулярная генетика, микробиология и вирусология. 2021; 39(4): 39-47.
4. Hortlund M., van Mol T., Van de Pol F., Bogers J., Dillner J. Human papillomavirus load and genotype analysis improves the prediction of invasive cervical cancer. Int. J. Cancer. 2021; 149(3): 684-91. https://dx.doi.org/10.1002/ijc.33519
5. Scott-Wittenborn N., Fakhry C. Epidemiology of HPV related malignancies. Semin. Radiat. Oncol. 2021; 31(4): 286-96. https://dx.doi.org/10.1016/j.semradonc.2021.04.001
6. Huber J., Mueller A., Sailer M., Regidor P.A. Human papillomavirus persistence or clearance after infection in reproductive age. What is the status? Review of the literature and new data of a vaginal gel containing silicate dioxide, citric acid, and selenite. Women’s Health. 2021; 17: 61-5. https://dx.doi.org/10.1177/17455065211020702
7. Hussain S., Tulsyan S., Dar S.A., Sisodiya S., Abiha U., Kumar R. et al. Role of epigenetics in carcinogenesis: recent advancements in anticancer therapy. Semin. Cancer Biol. 2022; 83: 441-51. https://dx.doi.org/10.1016/j.semcancer.2021.06.023
8. Mac M., Cary A.M. Epigenetic regulation of the human papillomavirus life cycle. Pathogens. 2020; 9(6): 483. https://dx.doi.org/10.3390/pathogens9060483
9. Cuschieri K., Ronco G., Lorincz A., Smith L., Ogilvie G., Mirabello L. et al. Eurogin roadmap 2017: Triage strategies for the management of HPV-positive women in cervical screening programs. International J. Cancer. 2018; 143(4): 735-45. https://dx.doi.org/10.1002/ijc.31261
10. Bowden S.J., Lathouras K., Kyrgiou M. Can DNA methylation tests improve the accuracy of cervical screening? BJOG. 2021; 128(3): 515. https://dx.doi.org/10.1111/1471-0528.16448
11. Clarke M.A., Luhn P., Gage J.C., Bodelon C., Dunn S.T., Walker J. et al. Discovery and validation of candidate host DNA methylation markers for detection of cervical precancer and cancer. International J. Cancer. 2017; 141(4): 701-10. https://dx.doi.org/10.1002/ijc.30781
12. Минниахметов И.Р., Забелин М.В., Ольков И.Г., Хусаинова Р.И. Пилотный проект по скринингу рака шейки матки с применением ВПЧ-тестирования. Вопросы онкологии. 2020; 66(6): 618-24.
13. Масюкова С.А., Киселев В.И., Потекаев Н.Н., Назарова М.Н., Полозников А.А., Бабкина И.О., Ахтямов С.Н., Тарасенко Э.Н. Изучение статуса метилирования гена WIF1 при ВПЧ-ассоциированных доброкачественных образованиях кожи и слизистых оболочек. Клиническая дерматология и венерология. 2017; 16(4): 38-43.
14. Байрамова Г.Р., Файзуллин Л.З., Королькова А.И., Полозников А.А., Киселев В.И. Скрининг рака шейки матки: что нового в мировой практике? Акушерство и гинекология. 2016; 7: 17-21.
15. Li H., Gao J., Zhang S. Functional and clinical characteristics of cell adhesion molecule CADM1 in cancer. Front. Cell Dev. Biol. 2021; 9: 714298. https://dx.doi.org/10.3389/fcell.2021.714298
16. Mersakova S., Holubekova V., Grendár M., Višňovský J., Ňachajová M., Kalman M. at al. Methylation of CADM1 and MAL together with HPV status in cytological cervical specimens serves an important role in the progression of cervical intraepithelial neoplasia. Oncology Letters. 2018; 16(6): 7166-74. https://dx.doi.org/10.3892/ol.2018.9505
17. van Baars R., van der Marel J., Snijders P.J., Rodriquez-Manfredi A., ter Harmsel B., van den Munckhof H.A. et al. CADM1 and MAL methylation status in cervical scrapes is representative of the most severe underlying lesion in women with multiple cervical biopsies. Int. J. Cancer. 2016; 138(2): 463-71. https://dx.doi.org/10.1002/ijc.29706
18. Kremer W.W., Steenbergen R., Heideman D., Kenter G.G., Meijer C. The use of host cell DNA methylation analysis in the detection and management of women with advanced cervical intraepithelial neoplasia: a review. BJOG. 2021; 128(3): 504-14. https://dx.doi.org/10.1111/1471-0528.16395
19. De Strooper L.M.A., Berkhof J., Steenbergen R.D.M., Lissenberg-Witte B.I., Snijders P.J.F., Meijer C.J.L.M. et al. Cervical cancer risk in HPV-positive women after a negative FAM19A4/mir124-2 methylation test: a post hoc analysis in the POBASCAM trial with 14 year follow-up. Int. J. Cancer. 2018; 143(6): 1541-8. https://dx.doi.org/10.1002/ijc.31539
20. Leeman A., Del Pino M., Marimon L., Torne A., Ordi J., Harmsel B.T. et al. Reliable identification of women with CIN3+ using hrHPV genotyping and methylation markers in a cytology-screened referral population. Int. J. Cancer. 2019; 144(1): 160-8. https://dx.doi.org/10.1002/ijc.31787
21. Vink F.J., Meijer C., Clifford G.M., Poljak M., Ostrbenk A., Petry K.U. et al. FAM19A4/miR124-2 methylation in invasive cervical cancer: a retrospective cross-sectional worldwide study. Int. J. Cancer. 2020; 147(4): 1215-21. https://dx.doi.org/10.1002/ijc.32614
22. Floore A., Hesselink A., Ostrbenk A., Alcaniz E., Rothe B., Pedersen H. et al. Intra- and inter-laboratory agreement of the FAM19A4/mir124-2 methylation test: results from an international study. J. Clini. Lab. Anal. 2019; 33(4): e22854. https://dx.doi.org/10.1002/jcla.22854
23. Bonde J., Floore A., Ejegod D., Vink F.J., Hesselink A., van de Ven P.M. et al. Methylation markers FAM19A4 and mir124-2 as triage strategy for primary human papillomavirus screen positive women: a large european multicenter study. Int. J. Cancer. 2021; 148(2): 396-405. https://dx.doi.org/10.1002/ijc.33320
24. Su P.H., Lai H.C., Huang R.L., Chen L.Y., Wang Y.C., Wuet T.I. et al. Paired box-1 (PAX1) activates multiple phosphatases and inhibits kinase cascades in cervical cancer. Sci. Rep. 2019; 9(1): 9195. https://dx.doi.org/10.1038/s41598-019-45477-5
25. Boers A., Wang R., van Leeuwen R.W., Klip H.G., de Bock G.H., Hollema H. et al. Discovery of new methylation markers to improve screening for cervical intraepithelial neoplasia grade 2/3. Clin. Epigenetics. 2016; 8: 29. https://dx.doi.org/10.1186/s13148-016-0196-3
26. van Leeuwen R.W., Oštrbenk A., Poljak M., van der Zee A.G.J., Schuuring E., Wisman G.B.A. DNA methylation markers as a triage test for identification of cervical lesions in a high risk human papillomavirus positive screening cohort. Int. J. Cancer. 2018; 144(4): 746-54. https://dx.doi.org/10.1002/ijc.31897
27. Kocsis A., Takacs T., Jeney C., Schaff Z., Koiss R., Jaray B. et al. Performance of a new HPV and biomarker assay in the management of hrHPV positive women: subanalysis of the ongoing multicenter TRACE clinical trial (n>6000) to evaluate POU4F3 methylation as a potential biomarker of cervical precancer and cancer. Int. J. Cancer. 2017; 140(5): 1119-33. https://dx.doi.org/10.1002/ijc.30534

Поступила 28.04.2025

Принята в печать 10.06.2025